Literature DB >> 26425056

Pain experience and expression in Rett syndrome: Subjective and objective measurement approaches.

Chantel C Barney1, Timothy Feyma2, Arthur Beisang2, Frank J Symons3.   

Abstract

Rett syndrome (RTT) is associated with myriad debilitating health issues and significant motor and communicative impairments. Because of the former there is concern about the possibility of recurrent and chronic pain but because of the latter it remains difficult to determine what pain 'looks like' in RTT. This study investigated pain experience and expression using multiple complementary subjective and objective approaches among a clinical RTT sample. Following informed consent, 18 participants (all female) with RTT (mean age= 12.8 years, SD= 6.32) were characterized in terms of pain experience and interference, typical pain expression, and elicited pain behavior during a passive range of motion-like examination procedure. Parents completed the Dalhousie Pain Interview (DPI; pain type, frequency, duration, intensity), the Brief Pain Inventory (BPI; pain interference), and the Non-Communicating Children's Pain Checklist - Revised (NCCPC-R; typical pain expression). A Pain Examination Procedure (PEP) was conducted and scored using the Pain and Discomfort Scale (PADS). The majority of the sample (89%) were reported to experience pain in the previous week which presented as gastrointestinal (n=8), musculoskeletal (n=5), and seizure related pain (n=5) that was intense (scored 0-10; M= 5.67, SD= 3.09) and long in duration (M= 25.22 hours, SD= 53.52). Numerous pain-expressive behaviors were inventoried (e.g., vocal, facial, mood/interaction changes) when parents reported their child's typical pain behaviors and based on independent direct observation during a reliably coded pain exam. This study provides subjective and objective evidence that individuals with RTT experience recurring and chronic pain for which pain expression appears intact.

Entities:  

Keywords:  MeCP2; Rett syndrome; measurement; neurodevelopmental disability; pain

Year:  2015        PMID: 26425056      PMCID: PMC4584146          DOI: 10.1007/s10882-015-9427-3

Source DB:  PubMed          Journal:  J Dev Phys Disabil        ISSN: 1056-263X


  23 in total

1.  An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001.

Authors:  Bengt Hagberg; Folker Hanefeld; Alan Percy; Ola Skjeldal
Journal:  Eur J Paediatr Neurol       Date:  2002       Impact factor: 3.140

Review 2.  Clinical manifestations and stages of Rett syndrome.

Authors:  Bengt Hagberg
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2002

Review 3.  A theoretical framework for understanding self-report and observational measures of pain: a communications model.

Authors:  T Hadjistavropoulos; K D Craig
Journal:  Behav Res Ther       Date:  2002-05

4.  Linking MECP2 and pain sensitivity: the example of Rett syndrome.

Authors:  Jenny Downs; Sandrine M Géranton; Ami Bebbington; Peter Jacoby; Nadia Bahi-Buisson; David Ravine; Helen Leonard
Journal:  Am J Med Genet A       Date:  2010-05       Impact factor: 2.802

5.  Measuring pain accurately in children with cognitive impairments: refinement of a caregiver scale.

Authors:  L M Breau; C Camfield; P J McGrath; C Rosmus; G A Finley
Journal:  J Pediatr       Date:  2001-05       Impact factor: 4.406

6.  The incidence of pain in children with severe cognitive impairments.

Authors:  Lynn M Breau; Carol S Camfield; Patrick J McGrath; G Allen Finley
Journal:  Arch Pediatr Adolesc Med       Date:  2003-12

7.  Expression of pain in children with autism.

Authors:  Rami Nader; Tim F Oberlander; Christine T Chambers; Kenneth D Craig
Journal:  Clin J Pain       Date:  2004 Mar-Apr       Impact factor: 3.442

8.  Parent-reported pain in Rett syndrome.

Authors:  Frank J Symons; Breanne Byiers; Raymond C Tervo; Arthur Beisang
Journal:  Clin J Pain       Date:  2013-08       Impact factor: 3.442

9.  A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome.

Authors:  Rodney C Samaco; John D Fryer; Jun Ren; Sharyl Fyffe; Hsiao-Tuan Chao; Yaling Sun; John J Greer; Huda Y Zoghbi; Jeffrey L Neul
Journal:  Hum Mol Genet       Date:  2008-03-04       Impact factor: 6.150

10.  Epigenetic programming of mu-opioid receptor gene in mouse brain is regulated by MeCP2 and Brg1 chromatin remodelling factor.

Authors:  Cheol Kyu Hwang; Kyu Young Song; Chun Sung Kim; Hack Sun Choi; Xiao-Hong Guo; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  J Cell Mol Med       Date:  2008-10-13       Impact factor: 5.310

View more
  13 in total

1.  Preliminary Evidence That Resting State Heart Rate Variability Predicts Reactivity to Tactile Stimuli in Rett Syndrome.

Authors:  Alyssa M Merbler; Breanne J Byiers; John Hoch; Adele C Dimian; Chantel C Barney; Timothy J Feyma; Arthur A Beisang; Alessandro Bartolomucci; Frank J Symons
Journal:  J Child Neurol       Date:  2019-09-25       Impact factor: 1.987

2.  A case-controlled comparison of postoperative analgesic dosing between girls with Rett syndrome and girls with and without developmental disability undergoing spinal fusion surgery.

Authors:  Chantel C Barney; Alyssa M Merbler; Kelsey Quest; Breanne J Byiers; George L Wilcox; Scott Schwantes; Samuel A Roiko; Timothy Feyma; Arthur Beisang; Frank J Symons
Journal:  Paediatr Anaesth       Date:  2017-02-08       Impact factor: 2.556

3.  Investigating the Feasibility of a Modified Quantitative Sensory Testing Approach to Profile Sensory Function and Predict Pain Outcomes Following Intrathecal Baclofen Implant Surgery in Cerebral Palsy.

Authors:  Chantel C Barney; Alyssa M Merbler; Donald A Simone; David Walk; Frank J Symons
Journal:  Pain Med       Date:  2020-01-01       Impact factor: 3.750

4.  Neuronal cytoskeletal gene dysregulation and mechanical hypersensitivity in a rat model of Rett syndrome.

Authors:  Aritra Bhattacherjee; Ying Mu; Michelle K Winter; Jennifer R Knapp; Linda S Eggimann; Sumedha S Gunewardena; Kazuto Kobayashi; Shigeki Kato; Dora Krizsan-Agbas; Peter G Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-31       Impact factor: 11.205

Review 5.  Movement disorders in patients with Rett syndrome: A systematic review of evidence and associated clinical considerations.

Authors:  Jatinder Singh; Evamaria Lanzarini; Nardo Nardocci; Paramala Santosh
Journal:  Psychiatry Clin Neurosci       Date:  2021-10-21       Impact factor: 12.145

6.  Motor, Somatosensory, Viscerosensory and Metabolic Impairments in a Heterozygous Female Rat Model of Rett Syndrome.

Authors:  Aritra Bhattacherjee; Michelle K Winter; Linda S Eggimann; Ying Mu; Sumedha Gunewardena; Zhaohui Liao; Julie A Christianson; Peter G Smith
Journal:  Int J Mol Sci       Date:  2017-12-29       Impact factor: 5.923

7.  A clinical case-control comparison of epidermal innervation density in Rett syndrome.

Authors:  Frank J Symons; Chantel C Barney; Breanne J Byiers; Brian D McAdams; Shawn X Y L Foster; Timothy J Feyma; Gwen Wendelschafer-Crabb; William R Kennedy
Journal:  Brain Behav       Date:  2019-04-13       Impact factor: 2.708

Review 8.  Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease.

Authors:  Shervin Pejhan; Mojgan Rastegar
Journal:  Biomolecules       Date:  2021-01-08

9.  The feasibility of using actigraphy to characterize sleep in Rett syndrome.

Authors:  Alyssa M Merbler; Breanne J Byiers; John J Garcia; Timothy J Feyma; Frank J Symons
Journal:  J Neurodev Disord       Date:  2018-02-27       Impact factor: 4.025

10.  Protective role of mirtazapine in adult female Mecp2+/- mice and patients with Rett syndrome.

Authors:  Javier Flores Gutiérrez; Claudio De Felice; Giulia Natali; Silvia Leoncini; Cinzia Signorini; Joussef Hayek; Enrico Tongiorgi
Journal:  J Neurodev Disord       Date:  2020-09-28       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.